| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |